Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
J. venom. anim. toxins incl. trop. dis ; 15(2): 289-304, 2009. ilus, graf
Article in English | LILACS, SES-SP | ID: lil-517287

ABSTRACT

Schistosomes use proteinases to accomplish some tasks such as tissue penetration, tissue digestion for nutrition and evasion of host immune responses. The Cathepsin L is a cysteine proteinase of the papain superfamily detected in the gut lumen indicating that this enzyme contributes to the proteolysis of ingested hemoglobin. Due to these roles they play in the schistosome biology, proteolytic enzymes are considered potential targets to develop and direct anti-schistosomal therapies. In this work, the cDNA coding Cathepsin L1 of Schistosoma mansoni was cloned into the pAE vector that provides high-level expression of heterologous proteins in Escherichia coli. The recombinant protein was expressed as inclusion bodies, purified under denaturing conditions through nickel charged chromatography and used for experimental animal vaccination. ELISA was performed with the pooled sera. Although this protein showed to be immunogenic, mice immunized with three doses of recombinant protein plus aluminum hydroxide as adjuvant did not protect against S. mansoni infection.


Subject(s)
Animals , Female , Mice , Schistosomiasis mansoni/prevention & control , Escherichia coli Proteins/therapeutic use , Vaccines
2.
Medicina (B.Aires) ; 66(supl.2): 33-36, 2006.
Article in Spanish | LILACS | ID: lil-480136

ABSTRACT

Cattle are recognized as the major reservoir of STEC and the source of infection for human beings. Until recently, intervention strategies to decrease the contamination of meat products have been focused on the slaughter plant with the application of practices to reduce the contamination and proliferation of STEC. This has now changed following the development of intervention strategies in the farm. This could be one of the most important points of intervention to lower the incidence of human infection. Vaccines, probiotics, bacteriophages, and changes in production practices may be useful as strategies to control EHEC in the cattle. The application of such intervention measures could be difficult due to the fact that this zoonotic agent rarely causes disease in bovines. The HUS is endemic in Argentina, and the factors leading to this epidemiological situation remain unknown. However, intervention strategies undoubtedly will contribute to reduce the incidence of this zoonosis.


Subject(s)
Humans , Animals , Cattle , Disease Reservoirs/microbiology , Escherichia coli Infections/prevention & control , /pathogenicity , Bacterial Proteins , Bacteriophages/immunology , Escherichia coli Infections/immunology , /virology , Escherichia coli Proteins/genetics , Escherichia coli Proteins/therapeutic use , Escherichia coli Vaccines/therapeutic use , Hemolytic-Uremic Syndrome/immunology , Hemolytic-Uremic Syndrome/prevention & control , Lactobacillus acidophilus , Phosphoproteins/genetics , Phosphoproteins/therapeutic use , Probiotics/therapeutic use , Shiga Toxin/biosynthesis , Shiga Toxin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL